Psychotropics and COVID-19: An analysis of safety and prophylaxis

The use of psychotropics during the COVID-19 pandemic has raised two questions, in order of importance: first, what changes should be made to pharmacological treatments prescribed to mental health patients? Secondly, are there any positive side effects of these substances against SARS-CoV-2? Our aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Javelot, H., Straczek, C., Meyer, G., Gitahy Falcao Faria, C., Weiner, L., Drapier, D., Fakra, E., Fossati, P., Weibel, S., Dizet, S., Langrée, B., Masson, M., Gaillard, R., Leboyer, M., Llorca, P.M., Hingray, C., Haffen, E., Yrondi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: L'Encéphale, Paris. 2021
Materias:
Review of the Literature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410507/
https://www.ncbi.nlm.nih.gov/pubmed/34548153
http://dx.doi.org/10.1016/j.encep.2021.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410507/
https://www.ncbi.nlm.nih.gov/pubmed/34548153
http://dx.doi.org/10.1016/j.encep.2021.08.002

Ejemplares similares